For: | Zhang Y, Wu D, Zhao B, Tian XL, Yao TC, Li F, Liu WF, Shi AP. Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature. World J Clin Cases 2021; 9(4): 919-926 [PMID: 33585640 DOI: 10.12998/wjcc.v9.i4.919] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v9/i4/919.htm |
Number | Citing Articles |
1 |
Nicolas-de-Jesus Sanchez-Casas, Leslie-Marisol Gonzalez-Hermosillo, Abril-Carolina Mendoza-Lopez, Elda-Lizeth Nava-Flores, Ernesto Roldan-Valadez. Infiltrating Metastatic Ductal Carcinoma Initially Presenting as Axillary Lymph
Node Metastases Diagnosed with PET/CT and MRI: Case Report and Brief
Review of Occult Breast Carcinoma. Current Medical Imaging Formerly Current Medical Imaging Reviews 2023; 20 doi: 10.2174/1573405620666230515090511
|
2 |
Nozomi Uozumi, Shoji Oura. Metastatic lymph nodes of occult breast cancer show very low internal echoes. Radiology Case Reports 2024; 19(10): 4163 doi: 10.1016/j.radcr.2024.06.068
|
3 |
Fuxiao Fang, Qing Yuan. Anlotinib inhibits the proliferation, migration and invasion, and induces apoptosis of breast cancer cells by downregulating TFAP2C. Oncology Letters 2021; 23(2) doi: 10.3892/ol.2021.13164
|
4 |
Kuojun Ren, Shuhan Wang, Tingbo Ye, Zhengzhi Zhu, Shikai Hong, Shengying Wang, Jianjun Liu. Efficacy and safety of Anlotinib based neoadjuvant chemotherapy for locally advanced triple negative breast cancer (TNBC). BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12852-z
|
5 |
Cem KARAALİ, Hüseyin ESİN, Emel Ebru PALA, Enver İLHAN. Okult Meme Kanserinde Neoadjuvan Kemoterapi: Bir Olgu Sunumu. İzmir Tıp Fakültesi Dergisi 2023; 2(2): 105 doi: 10.57221/izmirtip.1212817
|